Emily C Wong, Carlos X Castellanos, Tristan Grogan, Tsione Holly, John Patton, Benjamin Chu, Valeria Cárcamo-Cavazos, Andrea Poon, Parisa Partownavid, Siamak Rahman, Abie Mendelsohn
{"title":"Stellate Ganglion Blockade for Acute Pain Management After Transoral Robotic Surgery.","authors":"Emily C Wong, Carlos X Castellanos, Tristan Grogan, Tsione Holly, John Patton, Benjamin Chu, Valeria Cárcamo-Cavazos, Andrea Poon, Parisa Partownavid, Siamak Rahman, Abie Mendelsohn","doi":"10.1002/lary.70151","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Pharyngeal surgical site pain is a significant concern following transoral robotic surgery (TORS). The use of stellate ganglion blockade (SGB) has been reported as a treatment adjunct for postoperative pain.</p><p><strong>Methods: </strong>Patients who underwent TORS and neck dissection for oropharyngeal carcinoma between November 2019 and May 2021 by a single surgeon (AHM) were included. Patients underwent either SGB via injection of bupivacaine or no SGB. Inpatient pain and total daily morphine milligram equivalent (MME) usage were calculated. A retrospective chart review was performed to identify time in the OR spent placing the SGB, length of hospitalization, and postoperative complications.</p><p><strong>Results: </strong>Seventy-three patients were included. Of these, 43 (58.9%) underwent SGB. On average, SGB placement of any kind added 13 min to OR time prior to surgical start time. Patients who underwent SGB had significantly lower average pain scores over the postoperative time course (mean difference 0.75, 95% CI: 0.09-1.41, p = 0.027) and lower opioid consumption over time (mean difference 16.37 MME, 95% CI: 6.98-25.77, p < 0.001) compared with those who did not undergo SGB.</p><p><strong>Conclusion: </strong>SGB resulted in less narcotic pain medication use in the immediate postoperative period, without affecting length of hospitalization or rate of adverse events. SGB is a safe and effective adjunct to multimodal therapy for pain control in the postoperative period following TORS for laryngopharyngeal head and neck cancer.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/lary.70151","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Pharyngeal surgical site pain is a significant concern following transoral robotic surgery (TORS). The use of stellate ganglion blockade (SGB) has been reported as a treatment adjunct for postoperative pain.
Methods: Patients who underwent TORS and neck dissection for oropharyngeal carcinoma between November 2019 and May 2021 by a single surgeon (AHM) were included. Patients underwent either SGB via injection of bupivacaine or no SGB. Inpatient pain and total daily morphine milligram equivalent (MME) usage were calculated. A retrospective chart review was performed to identify time in the OR spent placing the SGB, length of hospitalization, and postoperative complications.
Results: Seventy-three patients were included. Of these, 43 (58.9%) underwent SGB. On average, SGB placement of any kind added 13 min to OR time prior to surgical start time. Patients who underwent SGB had significantly lower average pain scores over the postoperative time course (mean difference 0.75, 95% CI: 0.09-1.41, p = 0.027) and lower opioid consumption over time (mean difference 16.37 MME, 95% CI: 6.98-25.77, p < 0.001) compared with those who did not undergo SGB.
Conclusion: SGB resulted in less narcotic pain medication use in the immediate postoperative period, without affecting length of hospitalization or rate of adverse events. SGB is a safe and effective adjunct to multimodal therapy for pain control in the postoperative period following TORS for laryngopharyngeal head and neck cancer.
期刊介绍：
The Laryngoscope has been the leading source of information on advances in the diagnosis and treatment of head and neck disorders since 1890. The Laryngoscope is the first choice among otolaryngologists for publication of their important findings and techniques. Each monthly issue of The Laryngoscope features peer-reviewed medical, clinical, and research contributions in general otolaryngology, allergy/rhinology, otology/neurotology, laryngology/bronchoesophagology, head and neck surgery, sleep medicine, pediatric otolaryngology, facial plastics and reconstructive surgery, oncology, and communicative disorders. Contributions include papers and posters presented at the Annual and Section Meetings of the Triological Society, as well as independent papers, "How I Do It", "Triological Best Practice" articles, and contemporary reviews. Theses authored by the Triological Society’s new Fellows as well as papers presented at meetings of the American Laryngological Association are published in The Laryngoscope.
• Broncho-esophagology
• Communicative disorders
• Head and neck surgery
• Plastic and reconstructive facial surgery
• Oncology
• Speech and hearing defects
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
